COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey
Objectives We aimed to compare the spectrum and severity of COVID-19 and vaccine breakthrough infections (BIs) among patients with IIMs, other systemic autoimmune and inflammatory diseases (SAIDs), and healthy controls (HCs). Methods This is a cross-sectional study with data from the COVAD study, a...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Hoff, Leonardo Santos [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2022 |
|---|
| Schlagwörter: |
|---|
| Anmerkung: |
© The Author(s) 2022 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Rheumatology international - Berlin : Springer, 1981, 43(2022), 1 vom: 22. Okt., Seite 47-58 |
|---|---|
| Übergeordnetes Werk: |
volume:43 ; year:2022 ; number:1 ; day:22 ; month:10 ; pages:47-58 |
| Links: |
|---|
| DOI / URN: |
10.1007/s00296-022-05229-7 |
|---|
| Katalog-ID: |
SPR049420526 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR049420526 | ||
| 003 | DE-627 | ||
| 005 | 20230510060626.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00296-022-05229-7 |2 doi | |
| 035 | |a (DE-627)SPR049420526 | ||
| 035 | |a (SPR)s00296-022-05229-7-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hoff, Leonardo Santos |e verfasserin |0 (orcid)0000-0002-2083-4796 |4 aut | |
| 245 | 1 | 0 | |a COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2022 | ||
| 520 | |a Objectives We aimed to compare the spectrum and severity of COVID-19 and vaccine breakthrough infections (BIs) among patients with IIMs, other systemic autoimmune and inflammatory diseases (SAIDs), and healthy controls (HCs). Methods This is a cross-sectional study with data from the COVAD study, a self-reported online global survey that collected demographics, COVID-19 history, and vaccination details from April to September 2021. Adult patients with at least one COVID-19 vaccine dose were included. BIs were defined as infections occurring > 2 weeks after any dose of vaccine. Characteristics associated with BI were analyzed with a multivariate regression analysis. Results Among 10,900 respondents [42 (30–55) years, 74%-females, 45%-Caucasians] HCs were (47%), SAIDs (42%) and IIMs (11%). Patients with IIMs reported fewer COVID-19 cases before vaccination (6.2%-IIM vs 10.5%-SAIDs vs 14.6%-HC; OR = 0.6, 95% CI 0.4–0.8, and OR = 0.3, 95% CI 0.2–0.5, respectively). BIs were uncommon (1.4%-IIM; 1.9%-SAIDs; 3.2%-HC) and occurred in 17 IIM patients, 13 of whom were on immunosuppressants, and 3(18%) required hospitalization. All-cause hospitalization was higher in patients with IIM compared to HCs [23 (30%) vs 59 (8%), OR = 2.5, 95% CI 1.2–5.1 before vaccination, and 3 (18%) vs 9 (5%), OR = 2.6, 95% CI 1.3–5.3 in BI]. In a multivariate regression analysis, age 30–60 years was associated with a lower odds of BI (OR = 0.7, 95% CI 0.5–1.0), while the use of immunosuppressants had a higher odds of BI (OR = 1.6, 95% CI 1.1–2.7). Conclusions Patients with IIMs reported fewer COVID-19 cases than HCs and other SAIDs, but had higher odds of all-cause hospitalization from COVID-19 than HCs. BIs were associated with the use of immunosuppressants and were uncommon in IIMs. | ||
| 650 | 4 | |a Autoimmune diseases |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Breakthrough infection |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a COVID-19 |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Idiopathic inflammatory myopathies |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a SARS-CoV-2 vaccination |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Ravichandran, Naveen |0 (orcid)0000-0003-2014-3925 |4 aut | |
| 700 | 1 | |a Shinjo, Samuel Katsuyuki |0 (orcid)0000-0002-3682-4517 |4 aut | |
| 700 | 1 | |a Day, Jessica |0 (orcid)0000-0001-8528-4361 |4 aut | |
| 700 | 1 | |a Sen, Parikshit |0 (orcid)0000-0002-1630-6026 |4 aut | |
| 700 | 1 | |a Junior, Jucier Gonçalves |0 (orcid)0000-0001-5077-7959 |4 aut | |
| 700 | 1 | |a Lilleker, James B. |0 (orcid)0000-0002-9230-4137 |4 aut | |
| 700 | 1 | |a Joshi, Mrudula |0 (orcid)0000-0001-7312-351X |4 aut | |
| 700 | 1 | |a Agarwal, Vishwesh |0 (orcid)0000-0002-0986-8354 |4 aut | |
| 700 | 1 | |a Kardes, Sinan |0 (orcid)0000-0002-6311-8634 |4 aut | |
| 700 | 1 | |a Kim, Minchul |0 (orcid)0000-0001-9737-6255 |4 aut | |
| 700 | 1 | |a Milchert, Marcin |0 (orcid)0000-0002-0943-8768 |4 aut | |
| 700 | 1 | |a Makol, Ashima |0 (orcid)0000-0002-8748-898X |4 aut | |
| 700 | 1 | |a Gheita, Tamer |0 (orcid)0000-0002-1155-9729 |4 aut | |
| 700 | 1 | |a Salim, Babur |0 (orcid)0000-0001-8430-9299 |4 aut | |
| 700 | 1 | |a Velikova, Tsvetelina |0 (orcid)0000-0002-0593-1272 |4 aut | |
| 700 | 1 | |a Gracia-Ramos, Abraham Edgar |0 (orcid)0000-0003-1842-2554 |4 aut | |
| 700 | 1 | |a Parodis, Ioannis |0 (orcid)0000-0002-4875-5395 |4 aut | |
| 700 | 1 | |a O’Callaghan, Albert Selva |0 (orcid)0000-0003-2823-9761 |4 aut | |
| 700 | 1 | |a Nikiphorou, Elena |0 (orcid)0000-0001-6847-3726 |4 aut | |
| 700 | 1 | |a Tan, Ai Lyn |0 (orcid)0000-0002-9158-7243 |4 aut | |
| 700 | 1 | |a Chatterjee, Tulika |0 (orcid)0000-0001-8844-851X |4 aut | |
| 700 | 1 | |a Cavagna, Lorenzo |0 (orcid)0000-0003-3292-1528 |4 aut | |
| 700 | 1 | |a Saavedra, Miguel A. |0 (orcid)0000-0003-0687-9944 |4 aut | |
| 700 | 1 | |a Ziade, Nelly |0 (orcid)0000-0002-4479-7678 |4 aut | |
| 700 | 1 | |a Knitza, Johannes |0 (orcid)0000-0001-9695-0657 |4 aut | |
| 700 | 1 | |a Kuwana, Masataka |0 (orcid)0000-0001-8352-6136 |4 aut | |
| 700 | 1 | |a Nune, Arvind |0 (orcid)0000-0002-3849-614X |4 aut | |
| 700 | 1 | |a Distler, Oliver |0 (orcid)0000-0002-0546-8310 |4 aut | |
| 700 | 1 | |a Cansu, Döndü Üsküdar |0 (orcid)0000-0001-6543-3905 |4 aut | |
| 700 | 1 | |a Traboco, Lisa |0 (orcid)0000-0002-1952-7879 |4 aut | |
| 700 | 1 | |a Wibowo, Suryo Angorro Kusumo |0 (orcid)0000-0002-0089-0504 |4 aut | |
| 700 | 1 | |a Tehozol, Erick Adrian Zamora |0 (orcid)0000-0002-7888-3961 |4 aut | |
| 700 | 1 | |a Serrano, Jorge Rojas |0 (orcid)0000-0001-6980-7898 |4 aut | |
| 700 | 1 | |a La Torre, Ignacio García-De |0 (orcid)0000-0002-9261-678X |4 aut | |
| 700 | 1 | |a Wincup, Chris |0 (orcid)0000-0002-8742-8311 |4 aut | |
| 700 | 1 | |a Pauling, John D. |0 (orcid)0000-0002-2793-2364 |4 aut | |
| 700 | 1 | |a Chinoy, Hector |0 (orcid)0000-0001-6492-1288 |4 aut | |
| 700 | 1 | |a Agarwal, Vikas |0 (orcid)0000-0002-4508-1233 |4 aut | |
| 700 | 1 | |a Aggarwal, Rohit |0 (orcid)0000-0001-7531-8038 |4 aut | |
| 700 | 1 | |a Gupta, Latika |0 (orcid)0000-0003-2753-2990 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Rheumatology international |d Berlin : Springer, 1981 |g 43(2022), 1 vom: 22. Okt., Seite 47-58 |w (DE-627)265508320 |w (DE-600)1464208-6 |x 1437-160X |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2022 |g number:1 |g day:22 |g month:10 |g pages:47-58 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00296-022-05229-7 |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a GBV_ILN_11 | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_23 | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_32 | ||
| 912 | |a GBV_ILN_39 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_60 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a GBV_ILN_63 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_70 | ||
| 912 | |a GBV_ILN_73 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a GBV_ILN_90 | ||
| 912 | |a GBV_ILN_95 | ||
| 912 | |a GBV_ILN_100 | ||
| 912 | |a GBV_ILN_101 | ||
| 912 | |a GBV_ILN_105 | ||
| 912 | |a GBV_ILN_110 | ||
| 912 | |a GBV_ILN_120 | ||
| 912 | |a GBV_ILN_138 | ||
| 912 | |a GBV_ILN_150 | ||
| 912 | |a GBV_ILN_151 | ||
| 912 | |a GBV_ILN_152 | ||
| 912 | |a GBV_ILN_161 | ||
| 912 | |a GBV_ILN_170 | ||
| 912 | |a GBV_ILN_171 | ||
| 912 | |a GBV_ILN_187 | ||
| 912 | |a GBV_ILN_213 | ||
| 912 | |a GBV_ILN_224 | ||
| 912 | |a GBV_ILN_230 | ||
| 912 | |a GBV_ILN_250 | ||
| 912 | |a GBV_ILN_267 | ||
| 912 | |a GBV_ILN_281 | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a GBV_ILN_293 | ||
| 912 | |a GBV_ILN_370 | ||
| 912 | |a GBV_ILN_602 | ||
| 912 | |a GBV_ILN_636 | ||
| 912 | |a GBV_ILN_702 | ||
| 912 | |a GBV_ILN_711 | ||
| 912 | |a GBV_ILN_2001 | ||
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a GBV_ILN_2004 | ||
| 912 | |a GBV_ILN_2005 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a GBV_ILN_2007 | ||
| 912 | |a GBV_ILN_2008 | ||
| 912 | |a GBV_ILN_2009 | ||
| 912 | |a GBV_ILN_2010 | ||
| 912 | |a GBV_ILN_2011 | ||
| 912 | |a GBV_ILN_2014 | ||
| 912 | |a GBV_ILN_2015 | ||
| 912 | |a GBV_ILN_2020 | ||
| 912 | |a GBV_ILN_2021 | ||
| 912 | |a GBV_ILN_2025 | ||
| 912 | |a GBV_ILN_2026 | ||
| 912 | |a GBV_ILN_2027 | ||
| 912 | |a GBV_ILN_2031 | ||
| 912 | |a GBV_ILN_2034 | ||
| 912 | |a GBV_ILN_2037 | ||
| 912 | |a GBV_ILN_2038 | ||
| 912 | |a GBV_ILN_2039 | ||
| 912 | |a GBV_ILN_2044 | ||
| 912 | |a GBV_ILN_2048 | ||
| 912 | |a GBV_ILN_2049 | ||
| 912 | |a GBV_ILN_2050 | ||
| 912 | |a GBV_ILN_2055 | ||
| 912 | |a GBV_ILN_2056 | ||
| 912 | |a GBV_ILN_2057 | ||
| 912 | |a GBV_ILN_2059 | ||
| 912 | |a GBV_ILN_2061 | ||
| 912 | |a GBV_ILN_2064 | ||
| 912 | |a GBV_ILN_2065 | ||
| 912 | |a GBV_ILN_2068 | ||
| 912 | |a GBV_ILN_2088 | ||
| 912 | |a GBV_ILN_2093 | ||
| 912 | |a GBV_ILN_2106 | ||
| 912 | |a GBV_ILN_2107 | ||
| 912 | |a GBV_ILN_2108 | ||
| 912 | |a GBV_ILN_2110 | ||
| 912 | |a GBV_ILN_2111 | ||
| 912 | |a GBV_ILN_2112 | ||
| 912 | |a GBV_ILN_2113 | ||
| 912 | |a GBV_ILN_2118 | ||
| 912 | |a GBV_ILN_2122 | ||
| 912 | |a GBV_ILN_2129 | ||
| 912 | |a GBV_ILN_2143 | ||
| 912 | |a GBV_ILN_2144 | ||
| 912 | |a GBV_ILN_2147 | ||
| 912 | |a GBV_ILN_2148 | ||
| 912 | |a GBV_ILN_2152 | ||
| 912 | |a GBV_ILN_2153 | ||
| 912 | |a GBV_ILN_2188 | ||
| 912 | |a GBV_ILN_2190 | ||
| 912 | |a GBV_ILN_2232 | ||
| 912 | |a GBV_ILN_2336 | ||
| 912 | |a GBV_ILN_2446 | ||
| 912 | |a GBV_ILN_2470 | ||
| 912 | |a GBV_ILN_2472 | ||
| 912 | |a GBV_ILN_2507 | ||
| 912 | |a GBV_ILN_2522 | ||
| 912 | |a GBV_ILN_2548 | ||
| 912 | |a GBV_ILN_4035 | ||
| 912 | |a GBV_ILN_4037 | ||
| 912 | |a GBV_ILN_4046 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4126 | ||
| 912 | |a GBV_ILN_4242 | ||
| 912 | |a GBV_ILN_4246 | ||
| 912 | |a GBV_ILN_4249 | ||
| 912 | |a GBV_ILN_4251 | ||
| 912 | |a GBV_ILN_4277 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4306 | ||
| 912 | |a GBV_ILN_4307 | ||
| 912 | |a GBV_ILN_4313 | ||
| 912 | |a GBV_ILN_4322 | ||
| 912 | |a GBV_ILN_4323 | ||
| 912 | |a GBV_ILN_4324 | ||
| 912 | |a GBV_ILN_4325 | ||
| 912 | |a GBV_ILN_4326 | ||
| 912 | |a GBV_ILN_4328 | ||
| 912 | |a GBV_ILN_4333 | ||
| 912 | |a GBV_ILN_4334 | ||
| 912 | |a GBV_ILN_4335 | ||
| 912 | |a GBV_ILN_4336 | ||
| 912 | |a GBV_ILN_4338 | ||
| 912 | |a GBV_ILN_4393 | ||
| 912 | |a GBV_ILN_4700 | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2022 |e 1 |b 22 |c 10 |h 47-58 | ||
| author_variant |
l s h ls lsh n r nr s k s sk sks j d jd p s ps j g j jg jgj j b l jb jbl m j mj v a va s k sk m k mk m m mm a m am t g tg b s bs t v tv a e g r aeg aegr i p ip a s o as aso e n en a l t al alt t c tc l c lc m a s ma mas n z nz j k jk m k mk a n an o d od d ü c dü düc l t lt s a k w sak sakw e a z t eaz eazt j r s jr jrs t i g d l tigd tigdl c w cw j d p jd jdp h c hc v a va r a ra l g lg |
|---|---|
| matchkey_str |
article:1437160X:2022----::oi1svrtadacnbekhogifciniiiptiifamtrmoaheohrytmcuomuenifamtrdsaeadelhcnrlautcnecosetoasu |
| hierarchy_sort_str |
2022 |
| publishDate |
2022 |
| allfields |
10.1007/s00296-022-05229-7 doi (DE-627)SPR049420526 (SPR)s00296-022-05229-7-e DE-627 ger DE-627 rakwb eng Hoff, Leonardo Santos verfasserin (orcid)0000-0002-2083-4796 aut COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2022 Objectives We aimed to compare the spectrum and severity of COVID-19 and vaccine breakthrough infections (BIs) among patients with IIMs, other systemic autoimmune and inflammatory diseases (SAIDs), and healthy controls (HCs). Methods This is a cross-sectional study with data from the COVAD study, a self-reported online global survey that collected demographics, COVID-19 history, and vaccination details from April to September 2021. Adult patients with at least one COVID-19 vaccine dose were included. BIs were defined as infections occurring > 2 weeks after any dose of vaccine. Characteristics associated with BI were analyzed with a multivariate regression analysis. Results Among 10,900 respondents [42 (30–55) years, 74%-females, 45%-Caucasians] HCs were (47%), SAIDs (42%) and IIMs (11%). Patients with IIMs reported fewer COVID-19 cases before vaccination (6.2%-IIM vs 10.5%-SAIDs vs 14.6%-HC; OR = 0.6, 95% CI 0.4–0.8, and OR = 0.3, 95% CI 0.2–0.5, respectively). BIs were uncommon (1.4%-IIM; 1.9%-SAIDs; 3.2%-HC) and occurred in 17 IIM patients, 13 of whom were on immunosuppressants, and 3(18%) required hospitalization. All-cause hospitalization was higher in patients with IIM compared to HCs [23 (30%) vs 59 (8%), OR = 2.5, 95% CI 1.2–5.1 before vaccination, and 3 (18%) vs 9 (5%), OR = 2.6, 95% CI 1.3–5.3 in BI]. In a multivariate regression analysis, age 30–60 years was associated with a lower odds of BI (OR = 0.7, 95% CI 0.5–1.0), while the use of immunosuppressants had a higher odds of BI (OR = 1.6, 95% CI 1.1–2.7). Conclusions Patients with IIMs reported fewer COVID-19 cases than HCs and other SAIDs, but had higher odds of all-cause hospitalization from COVID-19 than HCs. BIs were associated with the use of immunosuppressants and were uncommon in IIMs. Autoimmune diseases (dpeaa)DE-He213 Breakthrough infection (dpeaa)DE-He213 COVID-19 (dpeaa)DE-He213 Idiopathic inflammatory myopathies (dpeaa)DE-He213 SARS-CoV-2 vaccination (dpeaa)DE-He213 Ravichandran, Naveen (orcid)0000-0003-2014-3925 aut Shinjo, Samuel Katsuyuki (orcid)0000-0002-3682-4517 aut Day, Jessica (orcid)0000-0001-8528-4361 aut Sen, Parikshit (orcid)0000-0002-1630-6026 aut Junior, Jucier Gonçalves (orcid)0000-0001-5077-7959 aut Lilleker, James B. (orcid)0000-0002-9230-4137 aut Joshi, Mrudula (orcid)0000-0001-7312-351X aut Agarwal, Vishwesh (orcid)0000-0002-0986-8354 aut Kardes, Sinan (orcid)0000-0002-6311-8634 aut Kim, Minchul (orcid)0000-0001-9737-6255 aut Milchert, Marcin (orcid)0000-0002-0943-8768 aut Makol, Ashima (orcid)0000-0002-8748-898X aut Gheita, Tamer (orcid)0000-0002-1155-9729 aut Salim, Babur (orcid)0000-0001-8430-9299 aut Velikova, Tsvetelina (orcid)0000-0002-0593-1272 aut Gracia-Ramos, Abraham Edgar (orcid)0000-0003-1842-2554 aut Parodis, Ioannis (orcid)0000-0002-4875-5395 aut O’Callaghan, Albert Selva (orcid)0000-0003-2823-9761 aut Nikiphorou, Elena (orcid)0000-0001-6847-3726 aut Tan, Ai Lyn (orcid)0000-0002-9158-7243 aut Chatterjee, Tulika (orcid)0000-0001-8844-851X aut Cavagna, Lorenzo (orcid)0000-0003-3292-1528 aut Saavedra, Miguel A. (orcid)0000-0003-0687-9944 aut Ziade, Nelly (orcid)0000-0002-4479-7678 aut Knitza, Johannes (orcid)0000-0001-9695-0657 aut Kuwana, Masataka (orcid)0000-0001-8352-6136 aut Nune, Arvind (orcid)0000-0002-3849-614X aut Distler, Oliver (orcid)0000-0002-0546-8310 aut Cansu, Döndü Üsküdar (orcid)0000-0001-6543-3905 aut Traboco, Lisa (orcid)0000-0002-1952-7879 aut Wibowo, Suryo Angorro Kusumo (orcid)0000-0002-0089-0504 aut Tehozol, Erick Adrian Zamora (orcid)0000-0002-7888-3961 aut Serrano, Jorge Rojas (orcid)0000-0001-6980-7898 aut La Torre, Ignacio García-De (orcid)0000-0002-9261-678X aut Wincup, Chris (orcid)0000-0002-8742-8311 aut Pauling, John D. (orcid)0000-0002-2793-2364 aut Chinoy, Hector (orcid)0000-0001-6492-1288 aut Agarwal, Vikas (orcid)0000-0002-4508-1233 aut Aggarwal, Rohit (orcid)0000-0001-7531-8038 aut Gupta, Latika (orcid)0000-0003-2753-2990 aut Enthalten in Rheumatology international Berlin : Springer, 1981 43(2022), 1 vom: 22. Okt., Seite 47-58 (DE-627)265508320 (DE-600)1464208-6 1437-160X nnns volume:43 year:2022 number:1 day:22 month:10 pages:47-58 https://dx.doi.org/10.1007/s00296-022-05229-7 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_120 GBV_ILN_138 GBV_ILN_150 GBV_ILN_151 GBV_ILN_152 GBV_ILN_161 GBV_ILN_170 GBV_ILN_171 GBV_ILN_187 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_250 GBV_ILN_267 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_636 GBV_ILN_702 GBV_ILN_711 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2031 GBV_ILN_2034 GBV_ILN_2037 GBV_ILN_2038 GBV_ILN_2039 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2057 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2088 GBV_ILN_2093 GBV_ILN_2106 GBV_ILN_2107 GBV_ILN_2108 GBV_ILN_2110 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2144 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2188 GBV_ILN_2190 GBV_ILN_2232 GBV_ILN_2336 GBV_ILN_2446 GBV_ILN_2470 GBV_ILN_2472 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_2548 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4046 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4246 GBV_ILN_4249 GBV_ILN_4251 GBV_ILN_4277 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4328 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4336 GBV_ILN_4338 GBV_ILN_4393 GBV_ILN_4700 AR 43 2022 1 22 10 47-58 |
| spelling |
10.1007/s00296-022-05229-7 doi (DE-627)SPR049420526 (SPR)s00296-022-05229-7-e DE-627 ger DE-627 rakwb eng Hoff, Leonardo Santos verfasserin (orcid)0000-0002-2083-4796 aut COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2022 Objectives We aimed to compare the spectrum and severity of COVID-19 and vaccine breakthrough infections (BIs) among patients with IIMs, other systemic autoimmune and inflammatory diseases (SAIDs), and healthy controls (HCs). Methods This is a cross-sectional study with data from the COVAD study, a self-reported online global survey that collected demographics, COVID-19 history, and vaccination details from April to September 2021. Adult patients with at least one COVID-19 vaccine dose were included. BIs were defined as infections occurring > 2 weeks after any dose of vaccine. Characteristics associated with BI were analyzed with a multivariate regression analysis. Results Among 10,900 respondents [42 (30–55) years, 74%-females, 45%-Caucasians] HCs were (47%), SAIDs (42%) and IIMs (11%). Patients with IIMs reported fewer COVID-19 cases before vaccination (6.2%-IIM vs 10.5%-SAIDs vs 14.6%-HC; OR = 0.6, 95% CI 0.4–0.8, and OR = 0.3, 95% CI 0.2–0.5, respectively). BIs were uncommon (1.4%-IIM; 1.9%-SAIDs; 3.2%-HC) and occurred in 17 IIM patients, 13 of whom were on immunosuppressants, and 3(18%) required hospitalization. All-cause hospitalization was higher in patients with IIM compared to HCs [23 (30%) vs 59 (8%), OR = 2.5, 95% CI 1.2–5.1 before vaccination, and 3 (18%) vs 9 (5%), OR = 2.6, 95% CI 1.3–5.3 in BI]. In a multivariate regression analysis, age 30–60 years was associated with a lower odds of BI (OR = 0.7, 95% CI 0.5–1.0), while the use of immunosuppressants had a higher odds of BI (OR = 1.6, 95% CI 1.1–2.7). Conclusions Patients with IIMs reported fewer COVID-19 cases than HCs and other SAIDs, but had higher odds of all-cause hospitalization from COVID-19 than HCs. BIs were associated with the use of immunosuppressants and were uncommon in IIMs. Autoimmune diseases (dpeaa)DE-He213 Breakthrough infection (dpeaa)DE-He213 COVID-19 (dpeaa)DE-He213 Idiopathic inflammatory myopathies (dpeaa)DE-He213 SARS-CoV-2 vaccination (dpeaa)DE-He213 Ravichandran, Naveen (orcid)0000-0003-2014-3925 aut Shinjo, Samuel Katsuyuki (orcid)0000-0002-3682-4517 aut Day, Jessica (orcid)0000-0001-8528-4361 aut Sen, Parikshit (orcid)0000-0002-1630-6026 aut Junior, Jucier Gonçalves (orcid)0000-0001-5077-7959 aut Lilleker, James B. (orcid)0000-0002-9230-4137 aut Joshi, Mrudula (orcid)0000-0001-7312-351X aut Agarwal, Vishwesh (orcid)0000-0002-0986-8354 aut Kardes, Sinan (orcid)0000-0002-6311-8634 aut Kim, Minchul (orcid)0000-0001-9737-6255 aut Milchert, Marcin (orcid)0000-0002-0943-8768 aut Makol, Ashima (orcid)0000-0002-8748-898X aut Gheita, Tamer (orcid)0000-0002-1155-9729 aut Salim, Babur (orcid)0000-0001-8430-9299 aut Velikova, Tsvetelina (orcid)0000-0002-0593-1272 aut Gracia-Ramos, Abraham Edgar (orcid)0000-0003-1842-2554 aut Parodis, Ioannis (orcid)0000-0002-4875-5395 aut O’Callaghan, Albert Selva (orcid)0000-0003-2823-9761 aut Nikiphorou, Elena (orcid)0000-0001-6847-3726 aut Tan, Ai Lyn (orcid)0000-0002-9158-7243 aut Chatterjee, Tulika (orcid)0000-0001-8844-851X aut Cavagna, Lorenzo (orcid)0000-0003-3292-1528 aut Saavedra, Miguel A. (orcid)0000-0003-0687-9944 aut Ziade, Nelly (orcid)0000-0002-4479-7678 aut Knitza, Johannes (orcid)0000-0001-9695-0657 aut Kuwana, Masataka (orcid)0000-0001-8352-6136 aut Nune, Arvind (orcid)0000-0002-3849-614X aut Distler, Oliver (orcid)0000-0002-0546-8310 aut Cansu, Döndü Üsküdar (orcid)0000-0001-6543-3905 aut Traboco, Lisa (orcid)0000-0002-1952-7879 aut Wibowo, Suryo Angorro Kusumo (orcid)0000-0002-0089-0504 aut Tehozol, Erick Adrian Zamora (orcid)0000-0002-7888-3961 aut Serrano, Jorge Rojas (orcid)0000-0001-6980-7898 aut La Torre, Ignacio García-De (orcid)0000-0002-9261-678X aut Wincup, Chris (orcid)0000-0002-8742-8311 aut Pauling, John D. (orcid)0000-0002-2793-2364 aut Chinoy, Hector (orcid)0000-0001-6492-1288 aut Agarwal, Vikas (orcid)0000-0002-4508-1233 aut Aggarwal, Rohit (orcid)0000-0001-7531-8038 aut Gupta, Latika (orcid)0000-0003-2753-2990 aut Enthalten in Rheumatology international Berlin : Springer, 1981 43(2022), 1 vom: 22. Okt., Seite 47-58 (DE-627)265508320 (DE-600)1464208-6 1437-160X nnns volume:43 year:2022 number:1 day:22 month:10 pages:47-58 https://dx.doi.org/10.1007/s00296-022-05229-7 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_120 GBV_ILN_138 GBV_ILN_150 GBV_ILN_151 GBV_ILN_152 GBV_ILN_161 GBV_ILN_170 GBV_ILN_171 GBV_ILN_187 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_250 GBV_ILN_267 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_636 GBV_ILN_702 GBV_ILN_711 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2031 GBV_ILN_2034 GBV_ILN_2037 GBV_ILN_2038 GBV_ILN_2039 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2057 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2088 GBV_ILN_2093 GBV_ILN_2106 GBV_ILN_2107 GBV_ILN_2108 GBV_ILN_2110 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2144 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2188 GBV_ILN_2190 GBV_ILN_2232 GBV_ILN_2336 GBV_ILN_2446 GBV_ILN_2470 GBV_ILN_2472 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_2548 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4046 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4246 GBV_ILN_4249 GBV_ILN_4251 GBV_ILN_4277 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4328 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4336 GBV_ILN_4338 GBV_ILN_4393 GBV_ILN_4700 AR 43 2022 1 22 10 47-58 |
| allfields_unstemmed |
10.1007/s00296-022-05229-7 doi (DE-627)SPR049420526 (SPR)s00296-022-05229-7-e DE-627 ger DE-627 rakwb eng Hoff, Leonardo Santos verfasserin (orcid)0000-0002-2083-4796 aut COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2022 Objectives We aimed to compare the spectrum and severity of COVID-19 and vaccine breakthrough infections (BIs) among patients with IIMs, other systemic autoimmune and inflammatory diseases (SAIDs), and healthy controls (HCs). Methods This is a cross-sectional study with data from the COVAD study, a self-reported online global survey that collected demographics, COVID-19 history, and vaccination details from April to September 2021. Adult patients with at least one COVID-19 vaccine dose were included. BIs were defined as infections occurring > 2 weeks after any dose of vaccine. Characteristics associated with BI were analyzed with a multivariate regression analysis. Results Among 10,900 respondents [42 (30–55) years, 74%-females, 45%-Caucasians] HCs were (47%), SAIDs (42%) and IIMs (11%). Patients with IIMs reported fewer COVID-19 cases before vaccination (6.2%-IIM vs 10.5%-SAIDs vs 14.6%-HC; OR = 0.6, 95% CI 0.4–0.8, and OR = 0.3, 95% CI 0.2–0.5, respectively). BIs were uncommon (1.4%-IIM; 1.9%-SAIDs; 3.2%-HC) and occurred in 17 IIM patients, 13 of whom were on immunosuppressants, and 3(18%) required hospitalization. All-cause hospitalization was higher in patients with IIM compared to HCs [23 (30%) vs 59 (8%), OR = 2.5, 95% CI 1.2–5.1 before vaccination, and 3 (18%) vs 9 (5%), OR = 2.6, 95% CI 1.3–5.3 in BI]. In a multivariate regression analysis, age 30–60 years was associated with a lower odds of BI (OR = 0.7, 95% CI 0.5–1.0), while the use of immunosuppressants had a higher odds of BI (OR = 1.6, 95% CI 1.1–2.7). Conclusions Patients with IIMs reported fewer COVID-19 cases than HCs and other SAIDs, but had higher odds of all-cause hospitalization from COVID-19 than HCs. BIs were associated with the use of immunosuppressants and were uncommon in IIMs. Autoimmune diseases (dpeaa)DE-He213 Breakthrough infection (dpeaa)DE-He213 COVID-19 (dpeaa)DE-He213 Idiopathic inflammatory myopathies (dpeaa)DE-He213 SARS-CoV-2 vaccination (dpeaa)DE-He213 Ravichandran, Naveen (orcid)0000-0003-2014-3925 aut Shinjo, Samuel Katsuyuki (orcid)0000-0002-3682-4517 aut Day, Jessica (orcid)0000-0001-8528-4361 aut Sen, Parikshit (orcid)0000-0002-1630-6026 aut Junior, Jucier Gonçalves (orcid)0000-0001-5077-7959 aut Lilleker, James B. (orcid)0000-0002-9230-4137 aut Joshi, Mrudula (orcid)0000-0001-7312-351X aut Agarwal, Vishwesh (orcid)0000-0002-0986-8354 aut Kardes, Sinan (orcid)0000-0002-6311-8634 aut Kim, Minchul (orcid)0000-0001-9737-6255 aut Milchert, Marcin (orcid)0000-0002-0943-8768 aut Makol, Ashima (orcid)0000-0002-8748-898X aut Gheita, Tamer (orcid)0000-0002-1155-9729 aut Salim, Babur (orcid)0000-0001-8430-9299 aut Velikova, Tsvetelina (orcid)0000-0002-0593-1272 aut Gracia-Ramos, Abraham Edgar (orcid)0000-0003-1842-2554 aut Parodis, Ioannis (orcid)0000-0002-4875-5395 aut O’Callaghan, Albert Selva (orcid)0000-0003-2823-9761 aut Nikiphorou, Elena (orcid)0000-0001-6847-3726 aut Tan, Ai Lyn (orcid)0000-0002-9158-7243 aut Chatterjee, Tulika (orcid)0000-0001-8844-851X aut Cavagna, Lorenzo (orcid)0000-0003-3292-1528 aut Saavedra, Miguel A. (orcid)0000-0003-0687-9944 aut Ziade, Nelly (orcid)0000-0002-4479-7678 aut Knitza, Johannes (orcid)0000-0001-9695-0657 aut Kuwana, Masataka (orcid)0000-0001-8352-6136 aut Nune, Arvind (orcid)0000-0002-3849-614X aut Distler, Oliver (orcid)0000-0002-0546-8310 aut Cansu, Döndü Üsküdar (orcid)0000-0001-6543-3905 aut Traboco, Lisa (orcid)0000-0002-1952-7879 aut Wibowo, Suryo Angorro Kusumo (orcid)0000-0002-0089-0504 aut Tehozol, Erick Adrian Zamora (orcid)0000-0002-7888-3961 aut Serrano, Jorge Rojas (orcid)0000-0001-6980-7898 aut La Torre, Ignacio García-De (orcid)0000-0002-9261-678X aut Wincup, Chris (orcid)0000-0002-8742-8311 aut Pauling, John D. (orcid)0000-0002-2793-2364 aut Chinoy, Hector (orcid)0000-0001-6492-1288 aut Agarwal, Vikas (orcid)0000-0002-4508-1233 aut Aggarwal, Rohit (orcid)0000-0001-7531-8038 aut Gupta, Latika (orcid)0000-0003-2753-2990 aut Enthalten in Rheumatology international Berlin : Springer, 1981 43(2022), 1 vom: 22. Okt., Seite 47-58 (DE-627)265508320 (DE-600)1464208-6 1437-160X nnns volume:43 year:2022 number:1 day:22 month:10 pages:47-58 https://dx.doi.org/10.1007/s00296-022-05229-7 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_120 GBV_ILN_138 GBV_ILN_150 GBV_ILN_151 GBV_ILN_152 GBV_ILN_161 GBV_ILN_170 GBV_ILN_171 GBV_ILN_187 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_250 GBV_ILN_267 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_636 GBV_ILN_702 GBV_ILN_711 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2031 GBV_ILN_2034 GBV_ILN_2037 GBV_ILN_2038 GBV_ILN_2039 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2057 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2088 GBV_ILN_2093 GBV_ILN_2106 GBV_ILN_2107 GBV_ILN_2108 GBV_ILN_2110 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2144 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2188 GBV_ILN_2190 GBV_ILN_2232 GBV_ILN_2336 GBV_ILN_2446 GBV_ILN_2470 GBV_ILN_2472 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_2548 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4046 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4246 GBV_ILN_4249 GBV_ILN_4251 GBV_ILN_4277 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4328 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4336 GBV_ILN_4338 GBV_ILN_4393 GBV_ILN_4700 AR 43 2022 1 22 10 47-58 |
| allfieldsGer |
10.1007/s00296-022-05229-7 doi (DE-627)SPR049420526 (SPR)s00296-022-05229-7-e DE-627 ger DE-627 rakwb eng Hoff, Leonardo Santos verfasserin (orcid)0000-0002-2083-4796 aut COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2022 Objectives We aimed to compare the spectrum and severity of COVID-19 and vaccine breakthrough infections (BIs) among patients with IIMs, other systemic autoimmune and inflammatory diseases (SAIDs), and healthy controls (HCs). Methods This is a cross-sectional study with data from the COVAD study, a self-reported online global survey that collected demographics, COVID-19 history, and vaccination details from April to September 2021. Adult patients with at least one COVID-19 vaccine dose were included. BIs were defined as infections occurring > 2 weeks after any dose of vaccine. Characteristics associated with BI were analyzed with a multivariate regression analysis. Results Among 10,900 respondents [42 (30–55) years, 74%-females, 45%-Caucasians] HCs were (47%), SAIDs (42%) and IIMs (11%). Patients with IIMs reported fewer COVID-19 cases before vaccination (6.2%-IIM vs 10.5%-SAIDs vs 14.6%-HC; OR = 0.6, 95% CI 0.4–0.8, and OR = 0.3, 95% CI 0.2–0.5, respectively). BIs were uncommon (1.4%-IIM; 1.9%-SAIDs; 3.2%-HC) and occurred in 17 IIM patients, 13 of whom were on immunosuppressants, and 3(18%) required hospitalization. All-cause hospitalization was higher in patients with IIM compared to HCs [23 (30%) vs 59 (8%), OR = 2.5, 95% CI 1.2–5.1 before vaccination, and 3 (18%) vs 9 (5%), OR = 2.6, 95% CI 1.3–5.3 in BI]. In a multivariate regression analysis, age 30–60 years was associated with a lower odds of BI (OR = 0.7, 95% CI 0.5–1.0), while the use of immunosuppressants had a higher odds of BI (OR = 1.6, 95% CI 1.1–2.7). Conclusions Patients with IIMs reported fewer COVID-19 cases than HCs and other SAIDs, but had higher odds of all-cause hospitalization from COVID-19 than HCs. BIs were associated with the use of immunosuppressants and were uncommon in IIMs. Autoimmune diseases (dpeaa)DE-He213 Breakthrough infection (dpeaa)DE-He213 COVID-19 (dpeaa)DE-He213 Idiopathic inflammatory myopathies (dpeaa)DE-He213 SARS-CoV-2 vaccination (dpeaa)DE-He213 Ravichandran, Naveen (orcid)0000-0003-2014-3925 aut Shinjo, Samuel Katsuyuki (orcid)0000-0002-3682-4517 aut Day, Jessica (orcid)0000-0001-8528-4361 aut Sen, Parikshit (orcid)0000-0002-1630-6026 aut Junior, Jucier Gonçalves (orcid)0000-0001-5077-7959 aut Lilleker, James B. (orcid)0000-0002-9230-4137 aut Joshi, Mrudula (orcid)0000-0001-7312-351X aut Agarwal, Vishwesh (orcid)0000-0002-0986-8354 aut Kardes, Sinan (orcid)0000-0002-6311-8634 aut Kim, Minchul (orcid)0000-0001-9737-6255 aut Milchert, Marcin (orcid)0000-0002-0943-8768 aut Makol, Ashima (orcid)0000-0002-8748-898X aut Gheita, Tamer (orcid)0000-0002-1155-9729 aut Salim, Babur (orcid)0000-0001-8430-9299 aut Velikova, Tsvetelina (orcid)0000-0002-0593-1272 aut Gracia-Ramos, Abraham Edgar (orcid)0000-0003-1842-2554 aut Parodis, Ioannis (orcid)0000-0002-4875-5395 aut O’Callaghan, Albert Selva (orcid)0000-0003-2823-9761 aut Nikiphorou, Elena (orcid)0000-0001-6847-3726 aut Tan, Ai Lyn (orcid)0000-0002-9158-7243 aut Chatterjee, Tulika (orcid)0000-0001-8844-851X aut Cavagna, Lorenzo (orcid)0000-0003-3292-1528 aut Saavedra, Miguel A. (orcid)0000-0003-0687-9944 aut Ziade, Nelly (orcid)0000-0002-4479-7678 aut Knitza, Johannes (orcid)0000-0001-9695-0657 aut Kuwana, Masataka (orcid)0000-0001-8352-6136 aut Nune, Arvind (orcid)0000-0002-3849-614X aut Distler, Oliver (orcid)0000-0002-0546-8310 aut Cansu, Döndü Üsküdar (orcid)0000-0001-6543-3905 aut Traboco, Lisa (orcid)0000-0002-1952-7879 aut Wibowo, Suryo Angorro Kusumo (orcid)0000-0002-0089-0504 aut Tehozol, Erick Adrian Zamora (orcid)0000-0002-7888-3961 aut Serrano, Jorge Rojas (orcid)0000-0001-6980-7898 aut La Torre, Ignacio García-De (orcid)0000-0002-9261-678X aut Wincup, Chris (orcid)0000-0002-8742-8311 aut Pauling, John D. (orcid)0000-0002-2793-2364 aut Chinoy, Hector (orcid)0000-0001-6492-1288 aut Agarwal, Vikas (orcid)0000-0002-4508-1233 aut Aggarwal, Rohit (orcid)0000-0001-7531-8038 aut Gupta, Latika (orcid)0000-0003-2753-2990 aut Enthalten in Rheumatology international Berlin : Springer, 1981 43(2022), 1 vom: 22. Okt., Seite 47-58 (DE-627)265508320 (DE-600)1464208-6 1437-160X nnns volume:43 year:2022 number:1 day:22 month:10 pages:47-58 https://dx.doi.org/10.1007/s00296-022-05229-7 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_120 GBV_ILN_138 GBV_ILN_150 GBV_ILN_151 GBV_ILN_152 GBV_ILN_161 GBV_ILN_170 GBV_ILN_171 GBV_ILN_187 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_250 GBV_ILN_267 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_636 GBV_ILN_702 GBV_ILN_711 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2031 GBV_ILN_2034 GBV_ILN_2037 GBV_ILN_2038 GBV_ILN_2039 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2057 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2088 GBV_ILN_2093 GBV_ILN_2106 GBV_ILN_2107 GBV_ILN_2108 GBV_ILN_2110 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2144 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2188 GBV_ILN_2190 GBV_ILN_2232 GBV_ILN_2336 GBV_ILN_2446 GBV_ILN_2470 GBV_ILN_2472 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_2548 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4046 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4246 GBV_ILN_4249 GBV_ILN_4251 GBV_ILN_4277 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4328 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4336 GBV_ILN_4338 GBV_ILN_4393 GBV_ILN_4700 AR 43 2022 1 22 10 47-58 |
| allfieldsSound |
10.1007/s00296-022-05229-7 doi (DE-627)SPR049420526 (SPR)s00296-022-05229-7-e DE-627 ger DE-627 rakwb eng Hoff, Leonardo Santos verfasserin (orcid)0000-0002-2083-4796 aut COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2022 Objectives We aimed to compare the spectrum and severity of COVID-19 and vaccine breakthrough infections (BIs) among patients with IIMs, other systemic autoimmune and inflammatory diseases (SAIDs), and healthy controls (HCs). Methods This is a cross-sectional study with data from the COVAD study, a self-reported online global survey that collected demographics, COVID-19 history, and vaccination details from April to September 2021. Adult patients with at least one COVID-19 vaccine dose were included. BIs were defined as infections occurring > 2 weeks after any dose of vaccine. Characteristics associated with BI were analyzed with a multivariate regression analysis. Results Among 10,900 respondents [42 (30–55) years, 74%-females, 45%-Caucasians] HCs were (47%), SAIDs (42%) and IIMs (11%). Patients with IIMs reported fewer COVID-19 cases before vaccination (6.2%-IIM vs 10.5%-SAIDs vs 14.6%-HC; OR = 0.6, 95% CI 0.4–0.8, and OR = 0.3, 95% CI 0.2–0.5, respectively). BIs were uncommon (1.4%-IIM; 1.9%-SAIDs; 3.2%-HC) and occurred in 17 IIM patients, 13 of whom were on immunosuppressants, and 3(18%) required hospitalization. All-cause hospitalization was higher in patients with IIM compared to HCs [23 (30%) vs 59 (8%), OR = 2.5, 95% CI 1.2–5.1 before vaccination, and 3 (18%) vs 9 (5%), OR = 2.6, 95% CI 1.3–5.3 in BI]. In a multivariate regression analysis, age 30–60 years was associated with a lower odds of BI (OR = 0.7, 95% CI 0.5–1.0), while the use of immunosuppressants had a higher odds of BI (OR = 1.6, 95% CI 1.1–2.7). Conclusions Patients with IIMs reported fewer COVID-19 cases than HCs and other SAIDs, but had higher odds of all-cause hospitalization from COVID-19 than HCs. BIs were associated with the use of immunosuppressants and were uncommon in IIMs. Autoimmune diseases (dpeaa)DE-He213 Breakthrough infection (dpeaa)DE-He213 COVID-19 (dpeaa)DE-He213 Idiopathic inflammatory myopathies (dpeaa)DE-He213 SARS-CoV-2 vaccination (dpeaa)DE-He213 Ravichandran, Naveen (orcid)0000-0003-2014-3925 aut Shinjo, Samuel Katsuyuki (orcid)0000-0002-3682-4517 aut Day, Jessica (orcid)0000-0001-8528-4361 aut Sen, Parikshit (orcid)0000-0002-1630-6026 aut Junior, Jucier Gonçalves (orcid)0000-0001-5077-7959 aut Lilleker, James B. (orcid)0000-0002-9230-4137 aut Joshi, Mrudula (orcid)0000-0001-7312-351X aut Agarwal, Vishwesh (orcid)0000-0002-0986-8354 aut Kardes, Sinan (orcid)0000-0002-6311-8634 aut Kim, Minchul (orcid)0000-0001-9737-6255 aut Milchert, Marcin (orcid)0000-0002-0943-8768 aut Makol, Ashima (orcid)0000-0002-8748-898X aut Gheita, Tamer (orcid)0000-0002-1155-9729 aut Salim, Babur (orcid)0000-0001-8430-9299 aut Velikova, Tsvetelina (orcid)0000-0002-0593-1272 aut Gracia-Ramos, Abraham Edgar (orcid)0000-0003-1842-2554 aut Parodis, Ioannis (orcid)0000-0002-4875-5395 aut O’Callaghan, Albert Selva (orcid)0000-0003-2823-9761 aut Nikiphorou, Elena (orcid)0000-0001-6847-3726 aut Tan, Ai Lyn (orcid)0000-0002-9158-7243 aut Chatterjee, Tulika (orcid)0000-0001-8844-851X aut Cavagna, Lorenzo (orcid)0000-0003-3292-1528 aut Saavedra, Miguel A. (orcid)0000-0003-0687-9944 aut Ziade, Nelly (orcid)0000-0002-4479-7678 aut Knitza, Johannes (orcid)0000-0001-9695-0657 aut Kuwana, Masataka (orcid)0000-0001-8352-6136 aut Nune, Arvind (orcid)0000-0002-3849-614X aut Distler, Oliver (orcid)0000-0002-0546-8310 aut Cansu, Döndü Üsküdar (orcid)0000-0001-6543-3905 aut Traboco, Lisa (orcid)0000-0002-1952-7879 aut Wibowo, Suryo Angorro Kusumo (orcid)0000-0002-0089-0504 aut Tehozol, Erick Adrian Zamora (orcid)0000-0002-7888-3961 aut Serrano, Jorge Rojas (orcid)0000-0001-6980-7898 aut La Torre, Ignacio García-De (orcid)0000-0002-9261-678X aut Wincup, Chris (orcid)0000-0002-8742-8311 aut Pauling, John D. (orcid)0000-0002-2793-2364 aut Chinoy, Hector (orcid)0000-0001-6492-1288 aut Agarwal, Vikas (orcid)0000-0002-4508-1233 aut Aggarwal, Rohit (orcid)0000-0001-7531-8038 aut Gupta, Latika (orcid)0000-0003-2753-2990 aut Enthalten in Rheumatology international Berlin : Springer, 1981 43(2022), 1 vom: 22. Okt., Seite 47-58 (DE-627)265508320 (DE-600)1464208-6 1437-160X nnns volume:43 year:2022 number:1 day:22 month:10 pages:47-58 https://dx.doi.org/10.1007/s00296-022-05229-7 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_120 GBV_ILN_138 GBV_ILN_150 GBV_ILN_151 GBV_ILN_152 GBV_ILN_161 GBV_ILN_170 GBV_ILN_171 GBV_ILN_187 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_250 GBV_ILN_267 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_636 GBV_ILN_702 GBV_ILN_711 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2031 GBV_ILN_2034 GBV_ILN_2037 GBV_ILN_2038 GBV_ILN_2039 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2057 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2088 GBV_ILN_2093 GBV_ILN_2106 GBV_ILN_2107 GBV_ILN_2108 GBV_ILN_2110 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2144 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2188 GBV_ILN_2190 GBV_ILN_2232 GBV_ILN_2336 GBV_ILN_2446 GBV_ILN_2470 GBV_ILN_2472 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_2548 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4046 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4246 GBV_ILN_4249 GBV_ILN_4251 GBV_ILN_4277 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4328 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4336 GBV_ILN_4338 GBV_ILN_4393 GBV_ILN_4700 AR 43 2022 1 22 10 47-58 |
| language |
English |
| source |
Enthalten in Rheumatology international 43(2022), 1 vom: 22. Okt., Seite 47-58 volume:43 year:2022 number:1 day:22 month:10 pages:47-58 |
| sourceStr |
Enthalten in Rheumatology international 43(2022), 1 vom: 22. Okt., Seite 47-58 volume:43 year:2022 number:1 day:22 month:10 pages:47-58 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Autoimmune diseases Breakthrough infection COVID-19 Idiopathic inflammatory myopathies SARS-CoV-2 vaccination |
| isfreeaccess_bool |
true |
| container_title |
Rheumatology international |
| authorswithroles_txt_mv |
Hoff, Leonardo Santos @@aut@@ Ravichandran, Naveen @@aut@@ Shinjo, Samuel Katsuyuki @@aut@@ Day, Jessica @@aut@@ Sen, Parikshit @@aut@@ Junior, Jucier Gonçalves @@aut@@ Lilleker, James B. @@aut@@ Joshi, Mrudula @@aut@@ Agarwal, Vishwesh @@aut@@ Kardes, Sinan @@aut@@ Kim, Minchul @@aut@@ Milchert, Marcin @@aut@@ Makol, Ashima @@aut@@ Gheita, Tamer @@aut@@ Salim, Babur @@aut@@ Velikova, Tsvetelina @@aut@@ Gracia-Ramos, Abraham Edgar @@aut@@ Parodis, Ioannis @@aut@@ O’Callaghan, Albert Selva @@aut@@ Nikiphorou, Elena @@aut@@ Tan, Ai Lyn @@aut@@ Chatterjee, Tulika @@aut@@ Cavagna, Lorenzo @@aut@@ Saavedra, Miguel A. @@aut@@ Ziade, Nelly @@aut@@ Knitza, Johannes @@aut@@ Kuwana, Masataka @@aut@@ Nune, Arvind @@aut@@ Distler, Oliver @@aut@@ Cansu, Döndü Üsküdar @@aut@@ Traboco, Lisa @@aut@@ Wibowo, Suryo Angorro Kusumo @@aut@@ Tehozol, Erick Adrian Zamora @@aut@@ Serrano, Jorge Rojas @@aut@@ La Torre, Ignacio García-De @@aut@@ Wincup, Chris @@aut@@ Pauling, John D. @@aut@@ Chinoy, Hector @@aut@@ Agarwal, Vikas @@aut@@ Aggarwal, Rohit @@aut@@ Gupta, Latika @@aut@@ |
| publishDateDaySort_date |
2022-10-22T00:00:00Z |
| hierarchy_top_id |
265508320 |
| id |
SPR049420526 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR049420526</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230510060626.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s00296-022-05229-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR049420526</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s00296-022-05229-7-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hoff, Leonardo Santos</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0002-2083-4796</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© The Author(s) 2022</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Objectives We aimed to compare the spectrum and severity of COVID-19 and vaccine breakthrough infections (BIs) among patients with IIMs, other systemic autoimmune and inflammatory diseases (SAIDs), and healthy controls (HCs). Methods This is a cross-sectional study with data from the COVAD study, a self-reported online global survey that collected demographics, COVID-19 history, and vaccination details from April to September 2021. Adult patients with at least one COVID-19 vaccine dose were included. BIs were defined as infections occurring > 2 weeks after any dose of vaccine. Characteristics associated with BI were analyzed with a multivariate regression analysis. Results Among 10,900 respondents [42 (30–55) years, 74%-females, 45%-Caucasians] HCs were (47%), SAIDs (42%) and IIMs (11%). Patients with IIMs reported fewer COVID-19 cases before vaccination (6.2%-IIM vs 10.5%-SAIDs vs 14.6%-HC; OR = 0.6, 95% CI 0.4–0.8, and OR = 0.3, 95% CI 0.2–0.5, respectively). BIs were uncommon (1.4%-IIM; 1.9%-SAIDs; 3.2%-HC) and occurred in 17 IIM patients, 13 of whom were on immunosuppressants, and 3(18%) required hospitalization. All-cause hospitalization was higher in patients with IIM compared to HCs [23 (30%) vs 59 (8%), OR = 2.5, 95% CI 1.2–5.1 before vaccination, and 3 (18%) vs 9 (5%), OR = 2.6, 95% CI 1.3–5.3 in BI]. In a multivariate regression analysis, age 30–60 years was associated with a lower odds of BI (OR = 0.7, 95% CI 0.5–1.0), while the use of immunosuppressants had a higher odds of BI (OR = 1.6, 95% CI 1.1–2.7). Conclusions Patients with IIMs reported fewer COVID-19 cases than HCs and other SAIDs, but had higher odds of all-cause hospitalization from COVID-19 than HCs. BIs were associated with the use of immunosuppressants and were uncommon in IIMs.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Autoimmune diseases</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breakthrough infection</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">COVID-19</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Idiopathic inflammatory myopathies</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">SARS-CoV-2 vaccination</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ravichandran, Naveen</subfield><subfield code="0">(orcid)0000-0003-2014-3925</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shinjo, Samuel Katsuyuki</subfield><subfield code="0">(orcid)0000-0002-3682-4517</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Day, Jessica</subfield><subfield code="0">(orcid)0000-0001-8528-4361</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sen, Parikshit</subfield><subfield code="0">(orcid)0000-0002-1630-6026</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Junior, Jucier Gonçalves</subfield><subfield code="0">(orcid)0000-0001-5077-7959</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lilleker, James B.</subfield><subfield code="0">(orcid)0000-0002-9230-4137</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Joshi, Mrudula</subfield><subfield code="0">(orcid)0000-0001-7312-351X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Agarwal, Vishwesh</subfield><subfield code="0">(orcid)0000-0002-0986-8354</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kardes, Sinan</subfield><subfield code="0">(orcid)0000-0002-6311-8634</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kim, Minchul</subfield><subfield code="0">(orcid)0000-0001-9737-6255</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Milchert, Marcin</subfield><subfield code="0">(orcid)0000-0002-0943-8768</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Makol, Ashima</subfield><subfield code="0">(orcid)0000-0002-8748-898X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gheita, Tamer</subfield><subfield code="0">(orcid)0000-0002-1155-9729</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Salim, Babur</subfield><subfield code="0">(orcid)0000-0001-8430-9299</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Velikova, Tsvetelina</subfield><subfield code="0">(orcid)0000-0002-0593-1272</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gracia-Ramos, Abraham Edgar</subfield><subfield code="0">(orcid)0000-0003-1842-2554</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Parodis, Ioannis</subfield><subfield code="0">(orcid)0000-0002-4875-5395</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">O’Callaghan, Albert Selva</subfield><subfield code="0">(orcid)0000-0003-2823-9761</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nikiphorou, Elena</subfield><subfield code="0">(orcid)0000-0001-6847-3726</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tan, Ai Lyn</subfield><subfield code="0">(orcid)0000-0002-9158-7243</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chatterjee, Tulika</subfield><subfield code="0">(orcid)0000-0001-8844-851X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cavagna, Lorenzo</subfield><subfield code="0">(orcid)0000-0003-3292-1528</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saavedra, Miguel A.</subfield><subfield code="0">(orcid)0000-0003-0687-9944</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ziade, Nelly</subfield><subfield code="0">(orcid)0000-0002-4479-7678</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Knitza, Johannes</subfield><subfield code="0">(orcid)0000-0001-9695-0657</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kuwana, Masataka</subfield><subfield code="0">(orcid)0000-0001-8352-6136</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nune, Arvind</subfield><subfield code="0">(orcid)0000-0002-3849-614X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Distler, Oliver</subfield><subfield code="0">(orcid)0000-0002-0546-8310</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cansu, Döndü Üsküdar</subfield><subfield code="0">(orcid)0000-0001-6543-3905</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Traboco, Lisa</subfield><subfield code="0">(orcid)0000-0002-1952-7879</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wibowo, Suryo Angorro Kusumo</subfield><subfield code="0">(orcid)0000-0002-0089-0504</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tehozol, Erick Adrian Zamora</subfield><subfield code="0">(orcid)0000-0002-7888-3961</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Serrano, Jorge Rojas</subfield><subfield code="0">(orcid)0000-0001-6980-7898</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">La Torre, Ignacio García-De</subfield><subfield code="0">(orcid)0000-0002-9261-678X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wincup, Chris</subfield><subfield code="0">(orcid)0000-0002-8742-8311</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pauling, John D.</subfield><subfield code="0">(orcid)0000-0002-2793-2364</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chinoy, Hector</subfield><subfield code="0">(orcid)0000-0001-6492-1288</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Agarwal, Vikas</subfield><subfield code="0">(orcid)0000-0002-4508-1233</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aggarwal, Rohit</subfield><subfield code="0">(orcid)0000-0001-7531-8038</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gupta, Latika</subfield><subfield code="0">(orcid)0000-0003-2753-2990</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Rheumatology international</subfield><subfield code="d">Berlin : Springer, 1981</subfield><subfield code="g">43(2022), 1 vom: 22. Okt., Seite 47-58</subfield><subfield code="w">(DE-627)265508320</subfield><subfield code="w">(DE-600)1464208-6</subfield><subfield code="x">1437-160X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:43</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:1</subfield><subfield code="g">day:22</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:47-58</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s00296-022-05229-7</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_32</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_90</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_101</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_120</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_138</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_150</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_171</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_187</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_250</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_267</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_281</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_636</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_711</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2004</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2006</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2007</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2008</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2010</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2020</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2021</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2025</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2026</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2031</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2034</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2038</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2039</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2044</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2048</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2049</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2050</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2056</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2057</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2059</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2061</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2064</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2065</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2068</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2088</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2093</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2106</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2107</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2108</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2113</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2118</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2122</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2129</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2143</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2144</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2147</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2148</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2153</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2188</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2232</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2336</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2446</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2470</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2472</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2507</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2522</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2548</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4035</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4046</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4242</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4246</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4251</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4277</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4326</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4328</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4333</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4334</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4335</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4336</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4393</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">43</subfield><subfield code="j">2022</subfield><subfield code="e">1</subfield><subfield code="b">22</subfield><subfield code="c">10</subfield><subfield code="h">47-58</subfield></datafield></record></collection>
|
| author |
Hoff, Leonardo Santos |
| spellingShingle |
Hoff, Leonardo Santos misc Autoimmune diseases misc Breakthrough infection misc COVID-19 misc Idiopathic inflammatory myopathies misc SARS-CoV-2 vaccination COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey |
| authorStr |
Hoff, Leonardo Santos |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)265508320 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1437-160X |
| topic_title |
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey Autoimmune diseases (dpeaa)DE-He213 Breakthrough infection (dpeaa)DE-He213 COVID-19 (dpeaa)DE-He213 Idiopathic inflammatory myopathies (dpeaa)DE-He213 SARS-CoV-2 vaccination (dpeaa)DE-He213 |
| topic |
misc Autoimmune diseases misc Breakthrough infection misc COVID-19 misc Idiopathic inflammatory myopathies misc SARS-CoV-2 vaccination |
| topic_unstemmed |
misc Autoimmune diseases misc Breakthrough infection misc COVID-19 misc Idiopathic inflammatory myopathies misc SARS-CoV-2 vaccination |
| topic_browse |
misc Autoimmune diseases misc Breakthrough infection misc COVID-19 misc Idiopathic inflammatory myopathies misc SARS-CoV-2 vaccination |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Rheumatology international |
| hierarchy_parent_id |
265508320 |
| hierarchy_top_title |
Rheumatology international |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)265508320 (DE-600)1464208-6 |
| title |
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey |
| ctrlnum |
(DE-627)SPR049420526 (SPR)s00296-022-05229-7-e |
| title_full |
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey |
| author_sort |
Hoff, Leonardo Santos |
| journal |
Rheumatology international |
| journalStr |
Rheumatology international |
| lang_code |
eng |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2022 |
| contenttype_str_mv |
txt |
| container_start_page |
47 |
| author_browse |
Hoff, Leonardo Santos Ravichandran, Naveen Shinjo, Samuel Katsuyuki Day, Jessica Sen, Parikshit Junior, Jucier Gonçalves Lilleker, James B. Joshi, Mrudula Agarwal, Vishwesh Kardes, Sinan Kim, Minchul Milchert, Marcin Makol, Ashima Gheita, Tamer Salim, Babur Velikova, Tsvetelina Gracia-Ramos, Abraham Edgar Parodis, Ioannis O’Callaghan, Albert Selva Nikiphorou, Elena Tan, Ai Lyn Chatterjee, Tulika Cavagna, Lorenzo Saavedra, Miguel A. Ziade, Nelly Knitza, Johannes Kuwana, Masataka Nune, Arvind Distler, Oliver Cansu, Döndü Üsküdar Traboco, Lisa Wibowo, Suryo Angorro Kusumo Tehozol, Erick Adrian Zamora Serrano, Jorge Rojas La Torre, Ignacio García-De Wincup, Chris Pauling, John D. Chinoy, Hector Agarwal, Vikas Aggarwal, Rohit Gupta, Latika |
| container_volume |
43 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Hoff, Leonardo Santos |
| doi_str_mv |
10.1007/s00296-022-05229-7 |
| normlink |
(ORCID)0000-0002-2083-4796 (ORCID)0000-0003-2014-3925 (ORCID)0000-0002-3682-4517 (ORCID)0000-0001-8528-4361 (ORCID)0000-0002-1630-6026 (ORCID)0000-0001-5077-7959 (ORCID)0000-0002-9230-4137 (ORCID)0000-0001-7312-351X (ORCID)0000-0002-0986-8354 (ORCID)0000-0002-6311-8634 (ORCID)0000-0001-9737-6255 (ORCID)0000-0002-0943-8768 (ORCID)0000-0002-8748-898X (ORCID)0000-0002-1155-9729 (ORCID)0000-0001-8430-9299 (ORCID)0000-0002-0593-1272 (ORCID)0000-0003-1842-2554 (ORCID)0000-0002-4875-5395 (ORCID)0000-0003-2823-9761 (ORCID)0000-0001-6847-3726 (ORCID)0000-0002-9158-7243 (ORCID)0000-0001-8844-851X (ORCID)0000-0003-3292-1528 (ORCID)0000-0003-0687-9944 (ORCID)0000-0002-4479-7678 (ORCID)0000-0001-9695-0657 (ORCID)0000-0001-8352-6136 (ORCID)0000-0002-3849-614X (ORCID)0000-0002-0546-8310 (ORCID)0000-0001-6543-3905 (ORCID)0000-0002-1952-7879 (ORCID)0000-0002-0089-0504 (ORCID)0000-0002-7888-3961 (ORCID)0000-0001-6980-7898 (ORCID)0000-0002-9261-678X (ORCID)0000-0002-8742-8311 (ORCID)0000-0002-2793-2364 (ORCID)0000-0001-6492-1288 (ORCID)0000-0002-4508-1233 (ORCID)0000-0001-7531-8038 (ORCID)0000-0003-2753-2990 |
| normlink_prefix_str_mv |
(orcid)0000-0002-2083-4796 (orcid)0000-0003-2014-3925 (orcid)0000-0002-3682-4517 (orcid)0000-0001-8528-4361 (orcid)0000-0002-1630-6026 (orcid)0000-0001-5077-7959 (orcid)0000-0002-9230-4137 (orcid)0000-0001-7312-351X (orcid)0000-0002-0986-8354 (orcid)0000-0002-6311-8634 (orcid)0000-0001-9737-6255 (orcid)0000-0002-0943-8768 (orcid)0000-0002-8748-898X (orcid)0000-0002-1155-9729 (orcid)0000-0001-8430-9299 (orcid)0000-0002-0593-1272 (orcid)0000-0003-1842-2554 (orcid)0000-0002-4875-5395 (orcid)0000-0003-2823-9761 (orcid)0000-0001-6847-3726 (orcid)0000-0002-9158-7243 (orcid)0000-0001-8844-851X (orcid)0000-0003-3292-1528 (orcid)0000-0003-0687-9944 (orcid)0000-0002-4479-7678 (orcid)0000-0001-9695-0657 (orcid)0000-0001-8352-6136 (orcid)0000-0002-3849-614X (orcid)0000-0002-0546-8310 (orcid)0000-0001-6543-3905 (orcid)0000-0002-1952-7879 (orcid)0000-0002-0089-0504 (orcid)0000-0002-7888-3961 (orcid)0000-0001-6980-7898 (orcid)0000-0002-9261-678X (orcid)0000-0002-8742-8311 (orcid)0000-0002-2793-2364 (orcid)0000-0001-6492-1288 (orcid)0000-0002-4508-1233 (orcid)0000-0001-7531-8038 (orcid)0000-0003-2753-2990 |
| title_sort |
covid-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the covid-19 vaccination in autoimmune diseases (covad) survey |
| title_auth |
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey |
| abstract |
Objectives We aimed to compare the spectrum and severity of COVID-19 and vaccine breakthrough infections (BIs) among patients with IIMs, other systemic autoimmune and inflammatory diseases (SAIDs), and healthy controls (HCs). Methods This is a cross-sectional study with data from the COVAD study, a self-reported online global survey that collected demographics, COVID-19 history, and vaccination details from April to September 2021. Adult patients with at least one COVID-19 vaccine dose were included. BIs were defined as infections occurring > 2 weeks after any dose of vaccine. Characteristics associated with BI were analyzed with a multivariate regression analysis. Results Among 10,900 respondents [42 (30–55) years, 74%-females, 45%-Caucasians] HCs were (47%), SAIDs (42%) and IIMs (11%). Patients with IIMs reported fewer COVID-19 cases before vaccination (6.2%-IIM vs 10.5%-SAIDs vs 14.6%-HC; OR = 0.6, 95% CI 0.4–0.8, and OR = 0.3, 95% CI 0.2–0.5, respectively). BIs were uncommon (1.4%-IIM; 1.9%-SAIDs; 3.2%-HC) and occurred in 17 IIM patients, 13 of whom were on immunosuppressants, and 3(18%) required hospitalization. All-cause hospitalization was higher in patients with IIM compared to HCs [23 (30%) vs 59 (8%), OR = 2.5, 95% CI 1.2–5.1 before vaccination, and 3 (18%) vs 9 (5%), OR = 2.6, 95% CI 1.3–5.3 in BI]. In a multivariate regression analysis, age 30–60 years was associated with a lower odds of BI (OR = 0.7, 95% CI 0.5–1.0), while the use of immunosuppressants had a higher odds of BI (OR = 1.6, 95% CI 1.1–2.7). Conclusions Patients with IIMs reported fewer COVID-19 cases than HCs and other SAIDs, but had higher odds of all-cause hospitalization from COVID-19 than HCs. BIs were associated with the use of immunosuppressants and were uncommon in IIMs. © The Author(s) 2022 |
| abstractGer |
Objectives We aimed to compare the spectrum and severity of COVID-19 and vaccine breakthrough infections (BIs) among patients with IIMs, other systemic autoimmune and inflammatory diseases (SAIDs), and healthy controls (HCs). Methods This is a cross-sectional study with data from the COVAD study, a self-reported online global survey that collected demographics, COVID-19 history, and vaccination details from April to September 2021. Adult patients with at least one COVID-19 vaccine dose were included. BIs were defined as infections occurring > 2 weeks after any dose of vaccine. Characteristics associated with BI were analyzed with a multivariate regression analysis. Results Among 10,900 respondents [42 (30–55) years, 74%-females, 45%-Caucasians] HCs were (47%), SAIDs (42%) and IIMs (11%). Patients with IIMs reported fewer COVID-19 cases before vaccination (6.2%-IIM vs 10.5%-SAIDs vs 14.6%-HC; OR = 0.6, 95% CI 0.4–0.8, and OR = 0.3, 95% CI 0.2–0.5, respectively). BIs were uncommon (1.4%-IIM; 1.9%-SAIDs; 3.2%-HC) and occurred in 17 IIM patients, 13 of whom were on immunosuppressants, and 3(18%) required hospitalization. All-cause hospitalization was higher in patients with IIM compared to HCs [23 (30%) vs 59 (8%), OR = 2.5, 95% CI 1.2–5.1 before vaccination, and 3 (18%) vs 9 (5%), OR = 2.6, 95% CI 1.3–5.3 in BI]. In a multivariate regression analysis, age 30–60 years was associated with a lower odds of BI (OR = 0.7, 95% CI 0.5–1.0), while the use of immunosuppressants had a higher odds of BI (OR = 1.6, 95% CI 1.1–2.7). Conclusions Patients with IIMs reported fewer COVID-19 cases than HCs and other SAIDs, but had higher odds of all-cause hospitalization from COVID-19 than HCs. BIs were associated with the use of immunosuppressants and were uncommon in IIMs. © The Author(s) 2022 |
| abstract_unstemmed |
Objectives We aimed to compare the spectrum and severity of COVID-19 and vaccine breakthrough infections (BIs) among patients with IIMs, other systemic autoimmune and inflammatory diseases (SAIDs), and healthy controls (HCs). Methods This is a cross-sectional study with data from the COVAD study, a self-reported online global survey that collected demographics, COVID-19 history, and vaccination details from April to September 2021. Adult patients with at least one COVID-19 vaccine dose were included. BIs were defined as infections occurring > 2 weeks after any dose of vaccine. Characteristics associated with BI were analyzed with a multivariate regression analysis. Results Among 10,900 respondents [42 (30–55) years, 74%-females, 45%-Caucasians] HCs were (47%), SAIDs (42%) and IIMs (11%). Patients with IIMs reported fewer COVID-19 cases before vaccination (6.2%-IIM vs 10.5%-SAIDs vs 14.6%-HC; OR = 0.6, 95% CI 0.4–0.8, and OR = 0.3, 95% CI 0.2–0.5, respectively). BIs were uncommon (1.4%-IIM; 1.9%-SAIDs; 3.2%-HC) and occurred in 17 IIM patients, 13 of whom were on immunosuppressants, and 3(18%) required hospitalization. All-cause hospitalization was higher in patients with IIM compared to HCs [23 (30%) vs 59 (8%), OR = 2.5, 95% CI 1.2–5.1 before vaccination, and 3 (18%) vs 9 (5%), OR = 2.6, 95% CI 1.3–5.3 in BI]. In a multivariate regression analysis, age 30–60 years was associated with a lower odds of BI (OR = 0.7, 95% CI 0.5–1.0), while the use of immunosuppressants had a higher odds of BI (OR = 1.6, 95% CI 1.1–2.7). Conclusions Patients with IIMs reported fewer COVID-19 cases than HCs and other SAIDs, but had higher odds of all-cause hospitalization from COVID-19 than HCs. BIs were associated with the use of immunosuppressants and were uncommon in IIMs. © The Author(s) 2022 |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_120 GBV_ILN_138 GBV_ILN_150 GBV_ILN_151 GBV_ILN_152 GBV_ILN_161 GBV_ILN_170 GBV_ILN_171 GBV_ILN_187 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_250 GBV_ILN_267 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_636 GBV_ILN_702 GBV_ILN_711 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2031 GBV_ILN_2034 GBV_ILN_2037 GBV_ILN_2038 GBV_ILN_2039 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2057 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2088 GBV_ILN_2093 GBV_ILN_2106 GBV_ILN_2107 GBV_ILN_2108 GBV_ILN_2110 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2144 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2188 GBV_ILN_2190 GBV_ILN_2232 GBV_ILN_2336 GBV_ILN_2446 GBV_ILN_2470 GBV_ILN_2472 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_2548 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4046 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4246 GBV_ILN_4249 GBV_ILN_4251 GBV_ILN_4277 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4328 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4336 GBV_ILN_4338 GBV_ILN_4393 GBV_ILN_4700 |
| container_issue |
1 |
| title_short |
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey |
| url |
https://dx.doi.org/10.1007/s00296-022-05229-7 |
| remote_bool |
true |
| author2 |
Ravichandran, Naveen Shinjo, Samuel Katsuyuki Day, Jessica Sen, Parikshit Junior, Jucier Gonçalves Lilleker, James B. Joshi, Mrudula Agarwal, Vishwesh Kardes, Sinan Kim, Minchul Milchert, Marcin Makol, Ashima Gheita, Tamer Salim, Babur Velikova, Tsvetelina Gracia-Ramos, Abraham Edgar Parodis, Ioannis O’Callaghan, Albert Selva Nikiphorou, Elena Tan, Ai Lyn Chatterjee, Tulika Cavagna, Lorenzo Saavedra, Miguel A. Ziade, Nelly Knitza, Johannes Kuwana, Masataka Nune, Arvind Distler, Oliver Cansu, Döndü Üsküdar Traboco, Lisa Wibowo, Suryo Angorro Kusumo Tehozol, Erick Adrian Zamora Serrano, Jorge Rojas La Torre, Ignacio García-De Wincup, Chris Pauling, John D. Chinoy, Hector Agarwal, Vikas Aggarwal, Rohit Gupta, Latika |
| author2Str |
Ravichandran, Naveen Shinjo, Samuel Katsuyuki Day, Jessica Sen, Parikshit Junior, Jucier Gonçalves Lilleker, James B. Joshi, Mrudula Agarwal, Vishwesh Kardes, Sinan Kim, Minchul Milchert, Marcin Makol, Ashima Gheita, Tamer Salim, Babur Velikova, Tsvetelina Gracia-Ramos, Abraham Edgar Parodis, Ioannis O’Callaghan, Albert Selva Nikiphorou, Elena Tan, Ai Lyn Chatterjee, Tulika Cavagna, Lorenzo Saavedra, Miguel A. Ziade, Nelly Knitza, Johannes Kuwana, Masataka Nune, Arvind Distler, Oliver Cansu, Döndü Üsküdar Traboco, Lisa Wibowo, Suryo Angorro Kusumo Tehozol, Erick Adrian Zamora Serrano, Jorge Rojas La Torre, Ignacio García-De Wincup, Chris Pauling, John D. Chinoy, Hector Agarwal, Vikas Aggarwal, Rohit Gupta, Latika |
| ppnlink |
265508320 |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s00296-022-05229-7 |
| up_date |
2024-07-04T00:43:46.553Z |
| _version_ |
1803607161236881408 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR049420526</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230510060626.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s00296-022-05229-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR049420526</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s00296-022-05229-7-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hoff, Leonardo Santos</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0002-2083-4796</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© The Author(s) 2022</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Objectives We aimed to compare the spectrum and severity of COVID-19 and vaccine breakthrough infections (BIs) among patients with IIMs, other systemic autoimmune and inflammatory diseases (SAIDs), and healthy controls (HCs). Methods This is a cross-sectional study with data from the COVAD study, a self-reported online global survey that collected demographics, COVID-19 history, and vaccination details from April to September 2021. Adult patients with at least one COVID-19 vaccine dose were included. BIs were defined as infections occurring > 2 weeks after any dose of vaccine. Characteristics associated with BI were analyzed with a multivariate regression analysis. Results Among 10,900 respondents [42 (30–55) years, 74%-females, 45%-Caucasians] HCs were (47%), SAIDs (42%) and IIMs (11%). Patients with IIMs reported fewer COVID-19 cases before vaccination (6.2%-IIM vs 10.5%-SAIDs vs 14.6%-HC; OR = 0.6, 95% CI 0.4–0.8, and OR = 0.3, 95% CI 0.2–0.5, respectively). BIs were uncommon (1.4%-IIM; 1.9%-SAIDs; 3.2%-HC) and occurred in 17 IIM patients, 13 of whom were on immunosuppressants, and 3(18%) required hospitalization. All-cause hospitalization was higher in patients with IIM compared to HCs [23 (30%) vs 59 (8%), OR = 2.5, 95% CI 1.2–5.1 before vaccination, and 3 (18%) vs 9 (5%), OR = 2.6, 95% CI 1.3–5.3 in BI]. In a multivariate regression analysis, age 30–60 years was associated with a lower odds of BI (OR = 0.7, 95% CI 0.5–1.0), while the use of immunosuppressants had a higher odds of BI (OR = 1.6, 95% CI 1.1–2.7). Conclusions Patients with IIMs reported fewer COVID-19 cases than HCs and other SAIDs, but had higher odds of all-cause hospitalization from COVID-19 than HCs. BIs were associated with the use of immunosuppressants and were uncommon in IIMs.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Autoimmune diseases</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breakthrough infection</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">COVID-19</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Idiopathic inflammatory myopathies</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">SARS-CoV-2 vaccination</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ravichandran, Naveen</subfield><subfield code="0">(orcid)0000-0003-2014-3925</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shinjo, Samuel Katsuyuki</subfield><subfield code="0">(orcid)0000-0002-3682-4517</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Day, Jessica</subfield><subfield code="0">(orcid)0000-0001-8528-4361</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sen, Parikshit</subfield><subfield code="0">(orcid)0000-0002-1630-6026</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Junior, Jucier Gonçalves</subfield><subfield code="0">(orcid)0000-0001-5077-7959</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lilleker, James B.</subfield><subfield code="0">(orcid)0000-0002-9230-4137</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Joshi, Mrudula</subfield><subfield code="0">(orcid)0000-0001-7312-351X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Agarwal, Vishwesh</subfield><subfield code="0">(orcid)0000-0002-0986-8354</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kardes, Sinan</subfield><subfield code="0">(orcid)0000-0002-6311-8634</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kim, Minchul</subfield><subfield code="0">(orcid)0000-0001-9737-6255</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Milchert, Marcin</subfield><subfield code="0">(orcid)0000-0002-0943-8768</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Makol, Ashima</subfield><subfield code="0">(orcid)0000-0002-8748-898X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gheita, Tamer</subfield><subfield code="0">(orcid)0000-0002-1155-9729</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Salim, Babur</subfield><subfield code="0">(orcid)0000-0001-8430-9299</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Velikova, Tsvetelina</subfield><subfield code="0">(orcid)0000-0002-0593-1272</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gracia-Ramos, Abraham Edgar</subfield><subfield code="0">(orcid)0000-0003-1842-2554</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Parodis, Ioannis</subfield><subfield code="0">(orcid)0000-0002-4875-5395</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">O’Callaghan, Albert Selva</subfield><subfield code="0">(orcid)0000-0003-2823-9761</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nikiphorou, Elena</subfield><subfield code="0">(orcid)0000-0001-6847-3726</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tan, Ai Lyn</subfield><subfield code="0">(orcid)0000-0002-9158-7243</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chatterjee, Tulika</subfield><subfield code="0">(orcid)0000-0001-8844-851X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cavagna, Lorenzo</subfield><subfield code="0">(orcid)0000-0003-3292-1528</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saavedra, Miguel A.</subfield><subfield code="0">(orcid)0000-0003-0687-9944</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ziade, Nelly</subfield><subfield code="0">(orcid)0000-0002-4479-7678</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Knitza, Johannes</subfield><subfield code="0">(orcid)0000-0001-9695-0657</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kuwana, Masataka</subfield><subfield code="0">(orcid)0000-0001-8352-6136</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nune, Arvind</subfield><subfield code="0">(orcid)0000-0002-3849-614X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Distler, Oliver</subfield><subfield code="0">(orcid)0000-0002-0546-8310</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cansu, Döndü Üsküdar</subfield><subfield code="0">(orcid)0000-0001-6543-3905</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Traboco, Lisa</subfield><subfield code="0">(orcid)0000-0002-1952-7879</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wibowo, Suryo Angorro Kusumo</subfield><subfield code="0">(orcid)0000-0002-0089-0504</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tehozol, Erick Adrian Zamora</subfield><subfield code="0">(orcid)0000-0002-7888-3961</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Serrano, Jorge Rojas</subfield><subfield code="0">(orcid)0000-0001-6980-7898</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">La Torre, Ignacio García-De</subfield><subfield code="0">(orcid)0000-0002-9261-678X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wincup, Chris</subfield><subfield code="0">(orcid)0000-0002-8742-8311</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pauling, John D.</subfield><subfield code="0">(orcid)0000-0002-2793-2364</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chinoy, Hector</subfield><subfield code="0">(orcid)0000-0001-6492-1288</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Agarwal, Vikas</subfield><subfield code="0">(orcid)0000-0002-4508-1233</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aggarwal, Rohit</subfield><subfield code="0">(orcid)0000-0001-7531-8038</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gupta, Latika</subfield><subfield code="0">(orcid)0000-0003-2753-2990</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Rheumatology international</subfield><subfield code="d">Berlin : Springer, 1981</subfield><subfield code="g">43(2022), 1 vom: 22. Okt., Seite 47-58</subfield><subfield code="w">(DE-627)265508320</subfield><subfield code="w">(DE-600)1464208-6</subfield><subfield code="x">1437-160X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:43</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:1</subfield><subfield code="g">day:22</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:47-58</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s00296-022-05229-7</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_32</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_90</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_101</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_120</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_138</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_150</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_171</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_187</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_250</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_267</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_281</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_636</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_711</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2004</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2006</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2007</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2008</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2010</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2020</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2021</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2025</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2026</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2031</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2034</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2038</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2039</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2044</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2048</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2049</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2050</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2056</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2057</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2059</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2061</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2064</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2065</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2068</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2088</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2093</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2106</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2107</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2108</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2113</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2118</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2122</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2129</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2143</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2144</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2147</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2148</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2153</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2188</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2232</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2336</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2446</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2470</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2472</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2507</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2522</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2548</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4035</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4046</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4242</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4246</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4251</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4277</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4326</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4328</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4333</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4334</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4335</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4336</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4393</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">43</subfield><subfield code="j">2022</subfield><subfield code="e">1</subfield><subfield code="b">22</subfield><subfield code="c">10</subfield><subfield code="h">47-58</subfield></datafield></record></collection>
|
| score |
7.4000845 |